SCHRODER INVESTMENT MANAGEMENT GROUP - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is and the CUSIP is 868459AD0. A total of 43 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
SCHRODER INVESTMENT MANAGEMENT GROUP ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$999,860
+2.4%
1,000,0000.0%0.00%
-50.0%
Q4 2022$976,574
+0.7%
1,000,0000.0%0.00%0.0%
Q3 2022$970,000
-0.1%
1,000,0000.0%0.00%
+100.0%
Q2 2022$971,000
-1.5%
1,000,0000.0%0.00%0.0%
Q1 2022$986,0001,000,0000.00%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Opti Capital Management, LP 37,347,000$36,345,0004.44%
CAMDEN ASSET MANAGEMENT L P /CA 51,663,000$49,804,0002.44%
Wellesley Asset Management 19,638$19,107,0002.29%
Radcliffe Capital Management, L.P. 58,877,000$56,759,0002.26%
DeepCurrents Investment Group LLC 29,151,000$28,254,0000.97%
Penn Mutual Asset Management, LLC 675,000$651,0000.74%
SHENKMAN CAPITAL MANAGEMENT INC 6,212,000$6,056,0000.71%
Sonora Investment Management, LLC 5,775,000$5,568,0000.44%
OAKTREE CAPITAL MANAGEMENT LP 22,802,000$22,095,0000.31%
WOLVERINE ASSET MANAGEMENT LLC 23,405,000$22,701,0000.19%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders